文献速递妇科

容积表观扩散系数(ADC)直方图指标作为影像生物标志物用于治疗前预测子宫内膜癌患者保留生育功能治疗的反应

Volumetric apparent diffusion coefficient (ADC) histogram metrics as imaging biomarkers for pretreatment predicting response to fertility-sparing treatment in patients with endometrial cancer.
PubMed 文献 · Gynecol Oncol · 2022-04-22

回顾性分析54例子宫内膜癌保留生育功能治疗(FST)患者的治疗前ADC直方图指标与临床特征,评估其与完全缓解(CR)及复发的关系。结果显示CR患者minADC等指标较高,minADC预测CR的AUC为0.688和0.735,联合年龄和HE4可提高至0.786;ADC指标与复发无关联。

要点

  • 治疗前minADC在第二次随访预测CR的AUC为0.688,第三次随访为0.735。
  • 连续两次CR的患者minADC显著高于未达连续两次CR者(P=0.018)。
  • 第三次随访联合年龄和HE4水平预测CR的AUC提高至0.786。

核心结论

  • 治疗前minADC可能是预测FST反应的潜在影像生物标志物。
  • 临床特征可能对minADC预测CR有增量价值。

研究设计与样本

  • 回顾性分析54例子宫内膜癌接受FST患者的治疗前数据。
  • 每次随访时通过病理评估治疗反应。
  • 采用单因素和多因素逻辑回归分析ADC直方图指标及基线临床特征与CR、连续两次CR及复发的关系。
  • 使用受试者工作特征(ROC)曲线分析评估诊断性能。

主要发现

  • 第二次随访时,CR患者较非CR患者minADC、第10和第25 ADC百分位数显著更高(P分别为0.008、0.039、0.034)。
  • 第三次随访时,CR患者较非CR患者minADC更高、年龄更大、HE4水平更低、超重率更高(P分别为0.001、0.040、0.021、0.004)。
  • 连续两次CR患者minADC显著高于未达连续两次CR者(P=0.018)。
  • ADC指标或临床特征与复发均无关联(所有P>0.05)。
  • minADC预测CR的AUC最大,第二次随访为0.688,第三次随访为0.735,预测连续两次CR的AUC为0.753。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To investigate the feasibility of volumetric apparent diffusion coefficient (ADC) histogram analysis for prediction of fertility-sparing treatment (FST) response in patients with endometrial cancer (EC). METHODS: Pretreatment data of 54 EC patients with FST were retrospectively analyzed. Treatment response at each follow-up was pathologically evaluated. The associations of ADC histogram metrics (volume, minADC, maxADC, meanADC; 10th, 25th, 50th, 75th and 90th ADC percentiles; skewness; kurtosis) and baseline clinical characteristics with complete response (CR) at the second and third follow-ups, two-consecutive CR, and recurrence at the final follow-up were evaluated by uni- and multivariable logistic regression analysis. Receiver operating characteristic (ROC) curve analysis was used for diagnostic performance evaluation. RESULTS: Compared with non-CR patients, CR patients had significantly higher minADC and 10th and 25th ADC percentiles at the second follow-up (P = 0.008, 0.039, and 0.034, respectively) and higher minADC, older age, lower HE4 level, and higher overweight rate at the third follow-up (P = 0.001, 0.040, 0.021, and 0.004, respectively). Patients with two-consecutive CR had a significantly higher minADC than those without (P = 0.018). There was no association between ADC metrics or clinical characteristics and recurrence (all P > 0.05). MinADC yielded the largest AUC in predicting CR (0.688 and 0.735 at the second and third follow-up, respectively) and the presence of two-consecutive CR (0.753). When combined with patient age and HE4 level, the prediction of CR could be further improved at the third follow-up, with an AUC of 0.786. CONCLUSION: Pretreatment minADC could be a potential imaging biomarker for predicting FST response. Clinical characteristics may have incremental value to minADC in predicting CR.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Ma X, Ren X, Ma F, et al. Volumetric apparent diffusion coefficient (ADC) histogram metrics as imaging biomarkers for pretreatment predicting response to fertility-sparing treatment in patients with endometrial cancer. Gynecol Oncol. 2022. PMID: 35469683. doi:10.1016/j.ygyno.2022.04.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。